Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 000210.KS
Valuation Somewhat Weak
43%
Profitability n.A.
Fin. Growth Weak
17%
Leverage & Liquidity Bad
0%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 11.20 1.00 0.90
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -31.85 18.00 26.41
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 2.14 173543.74 169901.14
Cash 8.77 46033.32 42320.09
Capex 60.84 -3563.64 -9100.12
Free Cash Flow -163.24 -3537.55 -1343.85
Revenue 12.58 62088.05 55148.30
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 27.09 0.25 0.20
Operating Margin 101.38 0.12 0.06
ROA -25.00 < 0.005 < 0.005
ROE -23.89 < 0.005 < 0.005
ROIC 66.01 0.01 < 0.005
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 000210.KS is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 000210.KS is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 000210.KS is permitted for members.